We are live on ! Find out more
RNVA

Rennova Health, Inc.
RNVA

Delisted

RNVA was delisted on the 24th of October, 2017.

1 hedge funds and large institutions have $0 invested in Rennova Health, Inc. in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% less funds holding

Funds holding: 91 (-8)

100% less capital invested

Capital invested by funds: $135K → $0 (-$135K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-8
Holders Change %
-88.89%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
-$91K -31,125 Closed
TSS
2
Two Sigma Securities
New York
-$19K -6,404 Closed
VF
3
Virtu Financial
New York
-$10K -3,565 Closed
UBS Group
4
UBS Group
Switzerland
-$6K -2,218 Closed
Bank of New York Mellon
5
Bank of New York Mellon
New York
-$6K -2,024 Closed
GC
6
Guggenheim Capital
Illinois
-$3K -1,188 Closed
IA
7
IFP Advisors
Florida
-$2 -1 -50%

RNVA Hedge Fund Activity: Q4 2017 in Review

1 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q4 2017, worth a combined $0 — down 100% from $135K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of RNVA and 0 opened new positions — a net loss of 8 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $91K sold.

  • 1 institutional investor held Rennova Health, Inc. (RNVA) as of Q4 2017, down from 9 in Q3 2017.
  • Funds reported $0 of Rennova Health, Inc. stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Rennova Health, Inc. positions in Q4 2017 and 8 closed out, a net change of -8 holders.
  • The largest Rennova Health, Inc. seller in Q4 2017 was Sabby Management, an estimated $91K sold.

Based on aggregated 13F filings for Q4 2017.